# Oxidative Stress-Induced DNA Damage Response Pathways in Aortic Disease: Implications for Inflammation and Vascular Degeneration

**Authors:** Sebastian Krych, Julia Gniewek, Marek Kolbowicz, Maria Adamczyk, Tomasz Hrapkowicz, Paweł Kowalczyk

PMC · DOI: 10.3390/ijms27041855 · International Journal of Molecular Sciences · 2026-02-14

## TL;DR

This paper reviews how DNA damage from oxidative stress contributes to aortic diseases by triggering inflammation and vascular degeneration.

## Contribution

The paper provides a comprehensive review of molecular mechanisms linking oxidative stress, DNA damage response, and aortic pathology.

## Key findings

- Oxidative DNA lesions activate DDR pathways in vascular cells, influencing cell fate and inflammation.
- DDR regulators like ATM, ATR, and p53 connect oxidative stress to vascular degeneration and inflammation.
- Phenotypic switching of smooth muscle cells and endothelial dysfunction are driven by DDR activation.

## Abstract

Aortic diseases, including thoracic and abdominal aneurysms as well as aortic dissections, represent life-threatening vascular disorders characterized by progressive wall degeneration and inflammation. Increasing evidence indicates that oxidative stress is a central driver of aortic pathology through the induction of DNA damage in vascular smooth muscle cells and endothelial cells. Oxidative DNA lesions activate the DNA damage response (DDR), a highly coordinated network of damage sensors, signaling kinases, and repair effectors that determines cell fate decisions such as DNA repair, apoptosis, or cellular senescence. In aortic tissue, persistent or dysregulated DDR signaling contributes to chronic inflammation, extracellular matrix degradation, and loss of vascular integrity. Key molecular regulators, including base excision repair enzymes OGG1 and APE1, as well as DDR mediators such as ATM, ATR, p53, PARP, and NOTCH1, integrate oxidative stress signals with pro-inflammatory and pro-degenerative pathways. Aberrant activation of these mechanisms promotes vascular smooth muscle cell VSMC phenotypic switching from contractile to synthetic phenotype, endothelial dysfunction, and senescence-associated secretory responses, thereby accelerating aortic wall weakening and aneurysm progression. This review highlights the mechanistic links between oxidative stress-induced DNA damage, DDR pathway activation, and vascular remodeling in aortopathies. A deeper understanding of these molecular interactions may uncover novel biomarkers and therapeutic targets aimed at limiting inflammation, preserving genomic stability, and preventing catastrophic aortic events. This work represents a narrative review and therefore has inherent limitations in terms of systematic literature search and selection.

## Linked entities

- **Genes:** OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968], APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328], ATM (ATM serine/threonine kinase) [NCBI Gene 472], ATR (ATR checkpoint kinase) [NCBI Gene 545], TP53 (tumor protein p53) [NCBI Gene 7157], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], NOTCH1 (notch receptor 1) [NCBI Gene 4851]

## Full-text entities

- **Genes:** fbn1 (fibrillin 1) [NCBI Gene 100330961] {aka fk65d08, si:ch73-34a12.4, wu:fk65d08}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, POLB (DNA polymerase beta) [NCBI Gene 5423], SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}, AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, MPO (myeloperoxidase) [NCBI Gene 4353], SMAD6 (SMAD family member 6) [NCBI Gene 4091] {aka AOVD2, HsT17432, MADH6, MADH7}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MYH11 (myosin heavy chain 11) [NCBI Gene 4629] {aka AAT4, FAA4, SMHC, SMMHC, SMMS-1, VSCM2}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, egf (epidermal growth factor) [NCBI Gene 403045] {aka sb:eu639}, RRBP1 (ribosome binding protein 1) [NCBI Gene 6238] {aka ES/130, ES130, RRp, hES, p180}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, MIR26A1 (microRNA 26a-1) [NCBI Gene 407015] {aka MIR26A, MIRN26A1, mir-26a-1}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SMAD2 (SMAD family member 2) [NCBI Gene 4087] {aka CHTD8, JV18, JV18-1, LDS6, MADH2, MADR2}, NOX1 (NADPH oxidase 1) [NCBI Gene 27035] {aka GP91-2, MOX1, NOH-1, NOH-1L, NOH1}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, MIR145 (microRNA 145) [NCBI Gene 406937] {aka MIRN145, miR-145, miRNA145}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MGMT (O-6-methylguanine-DNA methyltransferase) [NCBI Gene 4255], TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, MPG (N-methylpurine DNA glycosylase) [NCBI Gene 4350] {aka AAG, ADPG, APNG, CRA36.1, MDG, PIG11}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, MIR143 (microRNA 143) [NCBI Gene 406935] {aka MIRN143, mir-143}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, NOX4 (NADPH oxidase 4) [NCBI Gene 50507] {aka KOX, KOX-1, RENOX}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, FBN1 (fibrillin 1) [NCBI Gene 2200] {aka ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFLS}
- **Diseases:** cardiovascular abnormalities (MESH:D018376), VSMC Dysfunction (MESH:D018235), Haploinsufficiency (MESH:C565160), aortic tissue damage (MESH:D017695), chronic (MESH:D002908), medial (MESH:D020423), BAV (MESH:D000082882), Medial degeneration (MESH:D009410), skeletal anomalies (MESH:C535534), aortic wall (MESH:D056988), aortic remodeling (MESH:D020257), cardiovascular disease (MESH:D002318), aortic dilatation (MESH:D002311), AscAA (MESH:D000094625), vascular (MESH:D057772), vascular disorders (MESH:D002561), congenital heart defects (MESH:D006330), ECM Dysfunction (MESH:C535509), AAAs (MESH:D017544), Hemodynamic abnormalities (MESH:D000014), hypertension (MESH:D006973), autosomal dominant connective tissue disorder (MESH:D003240), DDR (MESH:C537658), skeletal overgrowth (MESH:C537340), aortic valve calcification (MESH:C562942), aneurysm formation (MESH:D058426), DNA Damage (MESH:D004266), autoimmune and inflammatory diseases (MESH:D001327), Marfan syndrome (MESH:D008382), inflammatory prostaglandin (MESH:C567786), aneurysm (MESH:D000783), endothelial dysfunction (MESH:D014652), TAAD (MESH:D000784), dilation and rupture (MESH:D012421), thoracic aortic disease (MESH:D013896), aneurysmal aortic (MESH:D001014), injury to (MESH:D014947), degenerative aortopathies (MESH:D019636), circulatory failure (MESH:D012769), Chronic vascular inflammation (MESH:D007249), Aortic Disease (MESH:D001018), fibrosis (MESH:D005355), TAAs (MESH:D017545), left ventricular outflow tract malformations (MESH:D000092242), congenital malformations (OMIM:163000), syndromic aortopathies (MESH:D013577), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** NAD+ (MESH:D009243), ROS (MESH:D017382), ATP (MESH:D000255), lipid (MESH:D008055), purine (MESH:C030985), cGAMP (MESH:C584311), RNS (MESH:D026361), 8-oxo-7,8-dihydroguanine (MESH:C024829), 1,N6-ethenoadenine (MESH:C004981), superoxide anion (MESH:D013481), 8-oxy-2'-deoxyguanosine (-), copper (MESH:D003300), NO (MESH:D009569), 8-oxo-dG (MESH:D000080242), purines (MESH:D011687), arachidonic acid (MESH:D016718), nitrogenous bases (MESH:D009711), prostaglandin (MESH:D011453), guanine (MESH:D006147), zinc (MESH:D015032), hypoxanthine (MESH:D019271)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** VSMC — Homo sapiens (Human), Finite cell line (CVCL_4009)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941246/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941246/full.md

## References

193 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941246/full.md

---
Source: https://tomesphere.com/paper/PMC12941246